New

Europe Laboratory Developed Test Market

2021

Biotechnology Europe Laboratory Developed Test Ma...

Europe Laboratory Developed Test Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Clinical Biochemistry, Critical Care, Haematology, Microbiology, Molecular Diagnostics, Immunology, and Other Test Types) and Application (Academic Institutes, Clinical Research Organizations, Hospitals Laboratory, Specialty Diagnostic Centers, and Others)

Publication Month: Nov 2021 | Report Code: TIPRE00025752 | No. of Pages: 120 | Category: Biotechnology | Status: Published

Market Insights

Europe Laboratory Developed Test Market to Grow at a CAGR of 6.8% to reach US$ 8,988.78 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The European laboratory developed test market is projected to reach US$ 8,988.78 million by 2028 from US$ 5,664.43 million in 2021; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028.

The increasing incidence of cancer and genetic disorders and the growing number of product launches across Europe are factors propelling the laboratory developed testing market. However, the changing regulatory landscape is hampering the growth of the laboratory development test market.

LDTs are developed and used within laboratories and not distributed or sold to other laboratories or healthcare facilities. These tests are designed to overcome the challenge of the unavailability of commercial tests. Many LDTs are genetic tests developed for rare diseases. Thus, the frequency of development and introduction of new LDTs is high. In November 2020, Aditx Therapeutics, Inc received a CLIA certification for AditxtScore laboratory operations for immune monitoring, which allowed them to launch the AditxtScore test to diagnose COVID-19. The increasing emergence of SARS-CoV-2 variants has highlighted the need to identify, trace, and track mutations across the complete viral genome. In January 2021, Eurofins launched the NovaType test for detecting and monitoring new variants of SARS-CoV-2. This RT-PCR assay is clinically validated for identifying B.1.1.7 and B.1.351 variants with a short time. NovaType is already available as an LDT in Germany, and it will be made available in over 50 Eurofins laboratories worldwide for testing patients for COVID-19. Also, the rising demand for personalized medicine is offering significant growth opportunities for the players operating in the European laboratory developed test market

Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating the pandemic. Many countries are declaring more cases each day than the first wave in 2020. The governments of many countries are working toward scaling up testing capacity, which is further driving the laboratory developed test market. Many market players have launched products to meet the growing demand. For instance, in August 2020, Eurofins Technologies (Luxembourg) launched a range of testing kits for serology-based antibody detection by ELISA of patients exposed to COVID-19. These tests are designed to meet the region-specific requirements for COVID-19. Viracor Eurofins received Food and Drug Administration (FDA) and Emergency Use Authorization (EUA) for its SARS-CoV-2 laboratory developed test. Other Eurofins laboratories have developed alternative RT-PCR options to meet local regulatory obligations and mitigate reagent supply chain issues globally. However, other non-emergency tests witnessed a drop due to lockdown measures and overburdened healthcare institutions.

European laboratory developed test market

Get more information on this report :



EUROPE LABORATORY DEVELOPED TEST MARKET SEGMENTATION

By Type

  • Clinical Biochemistry
  • Critical Care
  • Haematology
    • Coagulation and Hemostasis,
    • Hemoglobin Testing
    • Blood Count Testing
    • Others
  • Immunology
  • Microbiology
  • Molecular Diagnostics
  • Other Test Types

By Application

  • Academic Institutes
  • Clinical Research organizations
  • Hospitals laboratory
  • Specialty Diagnostic Centers
  • Others

By Country

  • Italy
  • France
  • Germany
  • Spain
  • UK
  • Rest of Europe

Company Profiles

  • Quest Diagnostics Incorporated
  • F.HOFFMANN-LA ROCHE LTD
  • QIAGEN
  • Illumina, Inc.
  • Eurofins Scientific
  • Guardant Health

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Laboratory Developed Test Market – By Type

1.3.2 Europe Laboratory Developed Test Market – By Application

1.3.3 Europe Laboratory Developed Test Market – By Country

2. Laboratory Developed Test Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Laboratory Developed Test Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe– PEST Analysis

4.3 Experts Opinion

5. Laboratory Developed Test Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Incidence of Cancer and Genetic Disorders

5.1.2 Large Number of Product Launches

5.2 Market Restraints

5.2.1 Changing Regulatory Landscape

5.3 Market Opportunities

5.3.1 Continuous Research on Personalized Medicine

5.4 Future Trends

5.4.1 Automation of Laboratory Processes

5.5 Impact Analysis

6. Laboratory Developed Test Market –Europe Analysis

6.1 Europe Laboratory Developed Test Market Revenue Forecast and Analysis

7. Laboratory Developed Test Market Analysis – By Type

7.1 Overview

7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)

7.3 Clinical Biochemistry

7.3.1 Overview

7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Haematology

7.4.1 Overview

7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Coagulation and Hemostasis

7.4.3.1 Overview

7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Hemoglobin Testing

7.4.4.1 Overview

7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Blood Count Testing

7.4.5.1 Overview

7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.6 Others

7.4.6.1 Overview

7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Immunology

7.5.1 Overview

7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Critical Care

7.6.1 Overview

7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Microbiology

7.7.1 Overview

7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Molecular Diagnostics

7.8.1 Overview

7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.9 Other Test Types

7.9.1 Overview

7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8. Laboratory Developed Test Market Analysis – By Application

8.1 Overview

8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)

8.3 Academic Institutes

8.3.1 Overview

8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Clinical Research organizations

8.4.1 Overview

8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Hospital laboratory

8.5.1 Overview

8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Specialty Diagnostic Centers

8.6.1 Overview

8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

9. Laboratory Developed Test Market – Europe Analysis

9.1 Europe: Laboratory Developed Test Market

9.1.1 Overview

9.1.3 Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)

9.1.3.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.2 Germany: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.1.2.1 Germany: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.1.3 Germany: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.2 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.1 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.2 France: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.2.2.1 France: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.2.3 France: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.3 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.1 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.2 UK: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.3.2.1 UK: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.3.3 UK: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.4 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.1 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.2 Italy: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.4.2.1 Italy: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.4.3 Italy: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.5 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.1 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.2 Spain: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.5.2.1 Spain: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.5.3 Spain: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.6 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.1 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.2 Rest of Europe: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.6.2.1 Rest of Europe: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.6.3 Rest of Europe: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Laboratory Developed Test Market

10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. Laboratory Developed Test Market–Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Quest Diagnostics Incorporated

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F.HOFFMANN-LA ROCHE LTD.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 QIAGEN

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Illumina, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Eurofins Scientific

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.7 Guardant Health

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms


LIST OF TABLES

Table 1. Germany: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 2. Germany Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 3. Germany: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4. France: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 5. France Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 6. France: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 7. UK: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 8. UK Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 9. UK: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10. Italy: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 11. Italy Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 12. Italy: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 13. Spain: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 14. Spain Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 15. Spain: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. Rest of Europe: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of Europe Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of Europe: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market

Table 20. Recent Organic Growth Strategies in the Laboratory Developed Test Market

Table 21. Glossary of Terms, Laboratory Developed Test Market


LIST OF FIGURES

Figure 1. Laboratory Developed Test Market Segmentation

Figure 2. Laboratory Developed Test Market Segmentation, By Country

Figure 3. Europe Laboratory Developed Test Market Overview

Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market

Figure 5. Europe Laboratory Developed Test Market – Leading Country Markets (US$ Million)

Figure 6. Europe and PEST Analysis

Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints

Figure 2. Europe Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028

Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)

Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)

Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Europe: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)

Figure 22. Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)

Figure 23. Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 24. France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 25. UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 26. Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 27. Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 28. Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. Impact of COVID-19 Pandemic in European Country Markets

  1. Quest Diagnostics Incorporated
  2. F.HOFFMANN-LA ROCHE LTD
  3. QIAGEN
  4. Illumina, Inc.
  5. Eurofins Scientific
  6. Guardant Health
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe laboratory developed test market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution. 
TIPRE00025752
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved